Desmethyl erlotinib carboxylate acid
CAS: 882172-60-3
Ref. 3D-FD21266
| 1mg | Descontinuado | ||
| 2mg | Descontinuado | ||
| 5mg | Descontinuado |
Informação sobre produto
Nome:
Desmethyl erlotinib carboxylate acid
Sinónimos:
- 2-[[4-[(3-Ethynylphenyl)amino]-6-(2-methoxyethoxy)-7-quinazolinyl]oxy]
Descrição:
Erlotinib is a drug that inhibits the enzyme tyrosine kinase, which is required for the growth and spread of cancer cells. It is used to treat patients with advanced non-small cell lung cancer and has been shown to have activity against other types of cancer. Erlotinib targets the epidermal growth factor receptor (EGFR), a protein that plays an important role in many cancers. Erlotinib binds to EGFR and prevents it from binding with its ligands, preventing signalling. Erlotinib also interacts with other proteins such as HER2/neu, c-kit, c-met, and PDGFRA/CD140B, which are involved in various cellular processes including proliferation, differentiation, apoptosis, and adhesion.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
393.39 g/mol
Fórmula:
C21H19N3O5
Pureza:
Min. 95%
InChI:
InChI=1S/CH4/h1H4
Chave InChI:
InChIKey=VNWKTOKETHGBQD-UHFFFAOYSA-N
SMILES:
C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCC(=O)O)cc23)c1
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
